Fangda Partners offers an extensive life sciences and healthcare focussed team representing an array of medical technology companies and investors, both PRC and multinational. The team is particularly recommended for its expertise in financing and fundraisings. Practice head Josh Shin is expert on regulatory-related issues including R&D, clinical trials, HGRAC regulation and patient centric transformation. Kate Yin is recommended for handling investigations work in the healthcare space, covering anti-bribery, accounting fraud, securities law, conflict of interest, trade secrets and data security. IP expert Fang Qi, antitrust investigations specialist Michael Han and the M&A and foreign investment focussed Diana Li are also central to the team. Henry He, who joined the firm from C-Stone Pharmaceuticals in January 2023, is a further key name.

Global Law Office‘s healthcare and life sciences team aims to provide a “one-stop” service for clients in the sector, handling M&A, investment and funding, licensing, day-to-day operational matters, IP protection, and compliance advice. The firm assists major MNCs in this capacity – including GSK, Roche and Amgen – as well as PRC state-owned enterprises. The practice is led jointly by Alan Zhou, a specialist in private equity and venture capital funds in the life sciences and medical technology field, and M&A and foreign direct investment specialist Michael Yu. Jerry Liu is also integral, with experience acting for investors as well as directly for biopharmaceutical companies. Licensing and collaboration agreements expert Charlene Huang, healthcare compliance specialist Coco Fan and certified fraud examiner Jacky Li are further key cogs in the team, as is associate Stephanie Wang.

Zhong Lun Law Firm‘s dedicated healthcare and life sciences practice is recommended for its breadth of capability in this space, covering M&A deals, investment funds, compliance advice and litigation, including trade secrets infringement cases. Changyu Fu is recommended for disputes and arbitration work in this field, including antitrust and criminal matters. Jim Qiu, who specialises in compliance advice for multinational clients operating in China, is also key, as is healthcare and medical technology IP expert Helen Cheng. Dongmei Wang and Yongbin Ge are further names to note. Among the more junior partners, medical product liability disputes expert Yuru Zuo and Qi Lan, who brings the experience of formerly having worked at the State Intellectual Property Office, are the standout names, while associate Shuman Zhang is also highly recommended. Clients describe the team as 'customer-focused, responsive, and problem-solving'.

Han Kun Law Offices has extensive capability in this space with branches of the team in Beijing, Shanghai, Shenzhen, Haikou and Wuhan. The firm is known for representing major multinational pharmaceutical and medical device companies, assisting with M&A deals and financing matters as well as licensing deals, data protection and intellectual property disputes. The team is led by Yinshi Cao, a venture capital and private equity fund investments specialist with a focus on the life sciences space. Aaron Gu is a standout name in the team, with experience advising on regulatory compliance matters in the areas of biologics and chemical drugs, medical devices and cosmetics. Corporate and commercial lawyer Min Zhu and life sciences M&A specialist Aaron Zhou are also key.

Haiwen & Partners acts for both PRC biotech companies and large foreign financial services investors, assisting with financing work in the healthcare and life sciences space. Practice head Tina Wu is also highly experienced in clinical research, product development and regulatory compliance matters. Key names on the transactional and investment funds side include Hao Bian and Wenzhen Dai.

Shihui Partners advises a range of PRC venture capital firms and medical technology companies on transactional and financing work, including licensing deals and development collaborations. Jing Lu, who is dual qualified in New York and the PRC and has experience in advising multinational pharmaceutical companies operating in China, leads the team jointly with capital markets and private equity specialists Miranda Jiang and Xiaomei Li. Zan Zhu is another key name to note. Clients recommend the firm for its 'very good' service quality and 'strong business logic'.

Tian Yuan Law Firm has a strong client base of innovative PRC enterprises, including producers of chronic disease management medication and ophthalmic medical devices. The firm focuses chiefly on financing work for these clients, with strength in capital markets and equity acquisitions. Practice head Juanjuan Song is experienced in transactional matters in the life sciences space including mergers and restructurings. She is supported by equity financing specialist Jiayun Xie and IPO expert Yan Liu.

Dacheng Law Offices is noted for its China wide capability, with offices across China’s regions, from Yunnan in the far south to Heilongjiang on the northern borders. The life sciences team regularly assists both start-ups and established PRC life sciences companies with financing work, with associate Shengdi Mao particularly recommended for handling capital markets and private equity investments in this sector. Andy (Xin) Wang is also integral, assisting with compliance and procurement matters in the life sciences space.

Jingtian & Gongcheng is recommended for handling acquisitions and equity takeovers in the PRC healthcare and life sciences market, regularly assisting Chinese companies in this capacity. The firm is also well-recommended for overseeing collaborations in this space, including between research and development companies and major hospitals. The team, which is noted for its ability to ‘understand the needs of customers and provide very practical and operable legal opinions‘, is jointly led by the corporate matters and licensing focussed Hanshuo Zhou and IPOs expert Yuanpeng Lang.